TRACE ELEMENTS FOR INJECTION - LIQ IV 10.42 MG / 5 ML
ZINC CHLORIDE : 10.42 MG / 5 ML CHROMIC CHLORIDE : .102 MG / 5 ML CUPRIC CHLORIDE : 2.68 MG / 5 ML MANGANESE CHLORIDE : 1.44 MG / 5 ML · DIN 02137143 · FAULDING (CANADA) INC.
Health Canada status: CANCELLED POST MARKET
What is TRACE ELEMENTS FOR INJECTION - LIQ IV?
TRACE ELEMENTS FOR INJECTION - LIQ IV 10.42 MG / 5 ML contains ZINC CHLORIDE : 10.42 MG / 5 ML CHROMIC CHLORIDE : .102 MG / 5 ML CUPRIC CHLORIDE : 2.68 MG / 5 ML MANGANESE CHLORIDE : 1.44 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02137143, held by FAULDING (CANADA) INC., supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 30-Jul-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02137143 |
|---|---|
| Brand name | TRACE ELEMENTS FOR INJECTION - LIQ IV |
| Generic / active ingredient | ZINC CHLORIDE : 10.42 MG / 5 ML CHROMIC CHLORIDE : .102 MG / 5 ML CUPRIC CHLORIDE : 2.68 MG / 5 ML MANGANESE CHLORIDE : 1.44 MG / 5 ML |
| Manufacturer | FAULDING (CANADA) INC. |
| Strength | 10.42 MG / 5 ML |
| Dosage form | LIQUID |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05XA31 ELECTROLYTES IN COMB WITH OTHER DRUGS |
| AHFS class | 40:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Jul-2001 |
| Original market date | 1998-06-15 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B05XA31 ELECTROLYTES IN COMB WITH OTHER DRUGS. 5 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ADDNUTRIV | 380 MCG / 10 ML | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02497697 |
| MICRO +4 REGULAR STRENGTH | 1 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02091135 |
| MICRO+ TE PEDIATRIC | 20 MCG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02536145 |
| MICRO+6 CONCENTRATE | 5 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02507587 |
| MICRO+6 REGULAR | 12 MCG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02552787 |
| MICRO PLUS 4 CONCENTRATE | 1 MG | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02091143 |
| MICRO PLUS 5 CONCENTRATE | 0.5 MG | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02091178 |
| MICRO PLUS 6 (CONCENTRATE) | 0.5 MG | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02091127 |
| MICRO PLUS 6 (PEDIATRIC) | 4 MCG | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02091100 |
| MICRO PLUS 6 (REGULAR) | 0.4 MG | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02091119 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.